Johns Hopkins ABX Guide
Enfuvirtide
INDICATIONS
FDA
FDA
- Indicated for use in combination with other ARV agents for treatment of HIV-1 infection in treatment-experienced patients with evidence of HIV replication despite ongoing ART.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: October 15, 2025
Citation
Dzintars, Kathryn. "Enfuvirtide." Johns Hopkins ABX Guide, The Johns Hopkins University, 2025. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540196/all/Enfuvirtide.
Dzintars K. Enfuvirtide. Johns Hopkins ABX Guide. The Johns Hopkins University; 2025. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540196/all/Enfuvirtide. Accessed November 1, 2025.
Dzintars, K. (2025). Enfuvirtide. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540196/all/Enfuvirtide
Dzintars K. Enfuvirtide [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2025. [cited 2025 November 01]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540196/all/Enfuvirtide.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Enfuvirtide
ID - 540196
A1 - Dzintars,Kathryn,Pharm.D., BCPS
Y1 - 2025/10/15/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540196/all/Enfuvirtide
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
